Citigroup’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
SWM
Citigroup's SMTI Position: Q2 2026 in Review
Citigroup increased its Sanara MedTech (SMTI) stake by 591% in Q2 2026, buying an estimated $71K and bringing the position to 4,016 shares worth $94.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4719.
Citigroup first reported a position in SMTI in Q4 2020 and has held it in 18 quarters since. The position peaked at $421K in Q4 2022. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.
- Citigroup held 4,016 shares of Sanara MedTech worth $94.7K as of Q2 2026.
- Citigroup bought 3,435 Sanara MedTech shares in Q2 2026, an estimated $71K.
- Sanara MedTech made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4719 holding.
- Citigroup first reported a position in Sanara MedTech in Q4 2020 and has held it in 18 quarters since.
- Citigroup's Sanara MedTech position peaked at $421K in Q4 2022.
- 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.